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Abstract 
Background: Malaria accounts for many deaths and illnesses, mostly among young children and pregnant women 
in sub‑Saharan Africa. An integrated approach is recommended to ensure effective malaria control. Socio‑cultural 
factors continue to serve as determinants of malaria health‑seeking behaviour. An INDEPTH effectiveness and safety 
study platform was established to unearth issues around the use of licensed and nationally recommended anti‑
malarials in real life settings. This study reports on treatment‑seeking behaviour for uncomplicated malaria among 
community members.
Methods: A qualitative study was conducted in the dry and rainy seasons in purposively selected communities in 
Kintampo north and south districts. This was based on distances to a health facility, ethnicity and availability of medi‑
cines at the sale outlets. Twenty‑four focus group discussions were conducted among adult men, women care‑takers 
of children less than 5 years and pregnant women. Ten INDEPTH interviews were also conducted among operators of 
medicine sale outlets and managers of health facilities. Fifty‑one illnesses narrative interviews were conducted among 
adult men, women, women caretakers of children less than 5 years and pregnant women. Transcripts were transferred 
into Nvivo 8 software for data management and analysis.
Results: The artemisinin‑based combinations that were commonly known and used were artesunate–amodiaquine 
and artemether–lumefantrine. Use of herbal preparation to treat diseases including uncomplicated malaria is rife in 
the communities. Drug stores were not the main source of artemisinin‑based combination sales at time of the study. 
Monotherapies, pain killers and other medicines were purchased from these shops for malaria treatment. Dizziness, 
general body weakness and sleepiness were noted among respondents who used artemisinin‑based combination 
therapy (ACT) in the past.
Conclusion: There is no clear cut trajectory for management of uncomplicated malaria in the study area. Different 
approaches are adopted when treating malaria. There is need for community education to influence behaviour on the 
management of malaria to achieve real gains from ACT use.
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Background
Malaria is still a major cause of deaths and illnesses; 
it affects mostly young children and pregnant women 
with the highest burden in sub-Saharan Africa. It was 
responsible for an estimated 482,000 deaths among chil-
dren under 5  years, 3.4 billion people worldwide are at 
risk of malaria infection, 90 % of all malaria deaths occur 
in sub Saharan Africa [1]. An integrated approach involv-
ing all the currently available tools is recommended. 
Access to treatment with effective anti-malarials need to 
be ensured, while also undertaking preventative measures 
such as targeted vector control [2]. Though some studies 
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have been carried out that described factors influencing 
treatment-seeking for malaria, far less is known about the 
relative weight given to these factors in different settings. 
Sociocultural research on malaria health-seeking behav-
iour recognizes issues influencing choice of provider 
for treatment [3, 4]. Other factors such as ethnicity also 
influences treatment-seeking with certain ethnic groups 
being much more reliant on traditional self-medication 
remedies [5, 6]. These sociocultural determinants of 
malaria health-seeking behaviour are often local and may 
change with time [7–9].
Product development Phase I, II and III randomized, 
controlled clinical trials have been well-supported and 
have established the initial safety and efficacy of such 
products when delivered under tightly monitored con-
ditions. However, there is very little experience with the 
effectiveness and safety evaluation of medicines deployed 
on a large scale within African health systems. An effec-
tiveness and safety platform was established by the 
INDEPTH network to document the safety and effective-
ness of artemisinin-based combination therapy (ACT) in 
real-life settings. This platform, INDEPTH Effectiveness 
and Safety Study (INESS) was established with the aim of 
minimizing the time gap between post-regulatory licen-
sure and adoption of new anti-malarials by providing 
timely safety and effectiveness data from endemic coun-
tries to guide national and global policies and practices.
Qualitative data was collected as part of this INESS ini-
tiative with the aim of identifying factors that influence 
community members’ ability to seek and receive appro-
priate treatment for malaria in Kintampo in the middle 
part of Ghana.
Methods
Study area
Data was collected from respondents in the Kintampo 
north and south districts in Ghana, between November 
2009 and July 2010. The two districts are located within 
the forest-savannah transitional ecological zone in the 
Brong-Ahafo Region, covering an area of 7162  km2. 
Malaria transmission is high with 269 infective bites per 
person per year with an all year round parasite preva-
lence of about 50  % among children <5  years of age 
[10]. The area’s resident population was 134,970 in 2009 
[11]. Community members are predominantly farm-
ers. Data were collected to coincide with the dry season 
(i.e. December 2009 to March 2010), a period that cor-
responds with low malaria transmission, and collection 
was repeated during the rainy season (i.e. April 2010 and 
October 2010), which corresponds to the high malaria 
transmission season.
The majority of inhabitants in this area initiate treat-
ment for some ailments at home, then continue to the 
Licensed Chemical Shops and may finally end up in a 
public health facility if their illness do not resolve [12]. 
There are two public hospitals, twelve health centres/
clinics and thirty community-based health planning and 
services (CHPS) compounds. These facilities provide 
health service delivery to urban as well as to the majority 
of deprived rural poor community members in the study 
area.
Data collection methods
Four rural communities located in the south and west of 
the Kintampo Districts were purposively selected for data 
collection based on availability/unavailability of health 
facilities as well as ethnic balance involving the two dom-
inant tribes in the study area.
Focus group discussions (FGDs)
Twenty-four FGDs were conducted separately, eight 
among adult men, eight among pregnant women and 
eight among caretakers of children less than 5  years of 
age in their respective communities. Compounds having 
potential discussants were randomly selected using the 
Kintampo Health and Demographic Surveillance System 
(KHDSS) database [11]. The selection criteria were: adults 
between 18 and 80  years who lived in the purposively 
selected communities. The potential discussants were 
identified in their various homes through the assistance of 
community opinion leaders. Respondents of different ages 
were put together to form a group of discussants. Males 
and females were put in separate groups for each discus-
sion session. Discussions were held in twi (the widely spo-
ken local dialect) all FGDs were held in either a church or 
an open space. The discussions were facilitated by a mod-
erator using an interview guide that was made up of pre-
determined questions and themes. Other related emerging 
issues were also discussed. Notes on responses and other 
non-verbal communications were also taken by a notes-
taker. Each session was digitally recorded; this was com-
plemented with the notes taken by the notes-taker during 
the results write up process. Each discussion session also 
lasted for about an hour. Interview sessions were brought 
an end when the moderator had exhausted all questions on 
the interview guide and other emerging issues. The FGDs 
assessed the care-seeking behaviour for malaria, knowl-
edge of malaria treatment and malaria treatments received 
at the health facilities and retail medicines sector. The 
perception of community members on how malaria treat-
ment works general knowledge and experiences with new 
anti-malarial drugs and their experiences with ACT, more 
specifically artesunate–amodiaquine. ACT contraindica-
tions were explored; their perceptions of the most effective 
and the less effective malaria treatment were also explored. 
A study team member moderated each interview session 
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while the responses were recorded by a second person to 
aid transcription and analysis. Interview sessions lasted 
between one and one and half hours and involved discus-
sants who numbered between eight and twelve.
In‑depth interviews (IDIs)
Ten in-depth interviews (IDIs) were conducted by a study 
team member, among health centre workers (4- 2 in Kin-
tampo North and South Districts respectively) and drug 
store operators (6- All in Kintampo South District). All the 
drug store operators and in-charges of health centres in 
both districts were interviewed. There were no drug stores 
in study communities in Kintampo North District as at 
the time of the study). Interviews among drug/chemical 
store operators were conducted in the premises where the 
medicines are sold to clients. Interviews were conducted 
when attendance was very low to avoid interruption by 
potential clients. Each session was digitally recorded; 
this was complemented by the notes taken by the notes-
taker during the results write- up process. Each interview 
session lasted for about thirty minutes to an hour. The 
health centre workers interviews centred on their hours 
of operation at the various health facilities and the type of 
services they provide, category of health personnel work-
ing in the facility; malaria diagnosis and treatment prac-
tices; patients preference for medicines and the reason(s) 
for their preference; perceptions on efficacy of medicines 
and their reasons for that perception; the types medicines 
patients request for, types of anti-malarial drugs in retail 
outlets and patients knowledge of malaria. In the case of 
medicine shop operators, interviews centred on the hours 
of operation at the various medicine shops, the services 
provided, anti-malarials including ACT available in the 
shop for sale, the type of ACT stocked and their source of 
supply; knowledge of malaria, clients medicine preference 
and the reason(s) for such preference, providers medicine 
preference and the reasons for this preference.
Illness narrative interview (INI)
The illness narrative interview was performed using an 
interview guide on the last episode of malaria, sources and 
sequence of treatment, preference for any particular type 
of treatment, perceived side effects and experiences with 
such treatments, perceptions about efficacious medicines 
and reasons for preference of such medicines. All persons 
who were ill with a fever in the past 2 weeks prior to the 
day of interview were eligible to be interviewed. Caretak-
ers responded on behalf of their under 5 years old children. 
INIs lasted between 10 and 25 min. All INIs were digitally 
recorded by a moderator who also made summaries and 
notes of non-verbal communication. Once the questions 
on the guide and other emerging issues are exhausted by 
the moderator, the interview session comes to an end.
A total of fifty-one INIs were conducted, 12 among 
men, 16 among women, 16 among women caretakers of 
children less than 5 years of age and 7 among pregnant 
women. Respondents were individuals in the study area 
that were part of the KHDSS database and have had an 
episode of malaria in the 2  weeks preceding the day of 
the illness narrative interview. Caretakers of children less 
than 5 years of age responded for their children who were 
qualified to be interviewed. To select respondents, a list 
of compounds was randomly generated from the KHDSS 
database. This was followed by a search through the com-
pounds for any member defined above who qualified for 
this interview. Those found were screened to ascertain 
eligibility and to ensure that not more than one category 
of respondent is selected from a compound. Respondents 
were interviewed on the sequence and types of treatment 
sought for that episode of malaria, the content of their 
consultation with health providers, the type of malaria 
treatment provided by health care providers, the percep-
tions of malaria treatment received, their opinions about 
best malaria medicines and malaria prevention and any 
malaria related issues in the communities.
Data management and analyses
Data from FGDs, IDIs and INIs were recorded using a 
digital recorder, transcribed verbatim, checked for com-
pleteness and accuracy; audio-recordings were vetted to 
match transcripts by the study team leader. The data were 
coded independently by two persons. To ensure inter-
coder agreement and reliability, 10  % of the transcripts 
were coded and this was followed with a debriefing ses-
sion to discuss the level of agreement. The level of agree-
ment between the independent coders was always above 
90 %. Responses were subsequently grouped and catego-
rized according to the themes under the study objectives 
and emerging themes as determined by the data using 
NVIVO version 8 qualitative data management software. 
Data were thematically analysed to identify themes that 
best addressed study’s objectives and related emerging 
themes. Responses that best describe the various themes 
served as quotes to support the findings. Table  1 gives 
details on how the data was analysed.
Ethical issues
Approval to conduct the INESS study was granted by 
the ethics committees of Ghana Health Service and the 
Kintampo Health Research Centre. Discussants and par-
ticipants in FGDs, IDIs and INIs were taken through an 
informed consent process; in which they either agreed 
or disagreed to be part of discussion/interview. Commu-
nity entry involved explaining the study to chiefs and key 
community opinion leaders. This was followed by pre-
paratory meetings with community opinion leaders and 
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other stakeholders from these communities to explain 
details of INESS and the objectives of the qualitative 
component, what their roles are and would be in the data 
collection processes.
Results
Characteristics of respondents
Table  2 gives a summary of the characteristics of 
respondents.
Community knowledge of ACT and availability of ACT 
at the community level
The artemisinin-based combinations that were com-
monly known and used by community members are 
artesunate–amodiaquine and artemether–lumefantrine. 
Artesunate–amodiaquine was commonly referred to as 
the “Yellow and white” tablets by respondents:
when I took that white and yellow, I only felt weak. 
That is the only thing I saw, apart from that, I did 
not experience any other side effect (FGD: Man)
He gave me drugs; one is white and the other is yel-
low. He also gave me blood tonic and para. (INI: 
Woman)
In some of the communities accessing ACT was a chal-
lenge. ACT was not available for community members to 
buy in time of need.
The white and yellow isn’t available at the drug store 
(FGD, pregnant woman)
Some community members mentioned only “amo-
diaquine” when they actually meant artesunate–
amodiaquine. Artesunate–amodiaquine, which is the 
first-line drug for the treatment of uncomplicated malaria 
is the ACT usually dispensed at the health facilities. 
Artemether–lumefantrine is dispensed by some health 
facilities in the study area.
As said earlier, amodiaquine is very good for the 
people of Amoma [referring to artesunate-amodi-
aquine] (FGD, Man)
The medicine sale outlets (Drug stores) do not normally 
dispense ACT. Community members therefore purchase 
monotherapies, pain killers and other drugs from them to 
treat malaria.
That is what I told you earlier that we do not sell 
drugs like artesunate–amodiaquine but we sell 
drugs like Quick Action [Caffein, Ephederine HCL, 
paracetamol] and efpac [acetylsalicylic acid, caf-
feine, paracetamol] which are always advertised on 
radio so if the person comes and we have to give him 
Efpac or Quick action, we tell him to take it three 
times a day (IDI, drug shop operator)
For malaria medicines we have malafan [sulfadox-
ine pyrimethamine, Amodiaquine syrup; first we 
have the tablet but now we do not get it that much 
and Kinaquin 442 [Chloroquine]. (IDI, Drug shop 
operator)
Table 1 How data collected in December 2009–October 2010 was analyzed
1 Two moderators coded data independently
2 10 % of data were independently coded and compared to ensure inter coder reliability and an agreement then reached on a coding tree
3 Themes were identified in advance and emerging themes were derived from data
4 Nvivo version 8 software was used for data management
5 Quotations were presented to illustrate themes. All quotes attributable to participants were anonimized
6 Major themes were clearly presented in the findings
7 There were descriptions of diverse cases and discussion of major themes
Table 2 Characteristics of respondents
Data collection method Age ranges 
of participants
Education level of participants
Men Women Men Women
Focus Group discussion 25–80 18–45 From no education to tertiary From no education to senior high school
INDEPTH Interview 35–52 53–56 From middle School leaving certificate to senior high school From middle school leaving certificate to 
Midwifery
Illness narrative interview 36–60 18–55 From no education‑ to general certificate of Education  
(ordinary level)
From no education to senior high school
Page 5 of 11Febir et al. Malar J  (2016) 15:108 
Experience with ACT
Respondents reported several experiences when they 
used ACT. Respondents generally held that, ACT make 
them weak and as such make them feel sleepy a lot and 
that one needs a long rest when taking ACT.
The drug causes you to sleep so when you take it you 
need to rest for about two to three hours else you 
become very weak (INI, woman)
Also respondents at INI sessions commonly mentioned 
that ACT can cause dizziness if a patient takes it without 
eating
Personally I feel dizzy when I take artesunate-amo-
diaquine without eating (INI: Man)
Others also mentioned that ACT cause them to vomit.
I came home just around this time. He asked me to 
take some of the drug so I took it. I also took some 
around one o’clock in the afternoon; he gave me three 
and asked me to try and take all in three days. So I 
took two in the morning and two in the afternoon; 
whilst taking it I felt the scent of the drug in my nose 
but I tried to swallow it. After taking it I felt like 
vomiting but I tried as much as possible to control it 
but I couldn’t so I had to vomit; that day I vomited a 
lot. (INI; pregnant woman)
Again, respondents mentioned that for ACT to work 
well and to prevent body weakness the patient must eat 
before taking it, apart from this they also mentioned the 
need to take the medicines as prescribed. Furthermore, 
respondents mentioned that ACT cause fast heart beat 
which will lead to some form of worry as mentioned 
below by respondent
…So I took two and half for two times, the moment you 
take the drug you feel dizzy. In about thirty minutes I 
felt sleepy, so I slept meaning the illness itself was cured. 
But with the sleep, no break, so my husband even asked 
whether I’ve taken some alcohol. (INI, Woman)
Respondents associated cure during a malaria episode 
with the following experiences during ACT treatment: 
“good sleep”, “urinate very well”, change in urine colour, 
excessive sweating, “yellow vomit”, eating “very well”, and 
reduction of a “child’s temperature and chills”.
When you sleep three hours after taking the drug you 
will sweat and when you urinate you will see the dif-
ference. Thus the colour of your urine will change. 
(FGD: Man)
So after taking the drug, you realize that your tem-
perature comes down; and with the weakness, you 
not even able to go out to urinate. So, having taken 
the drug and when it begins to work, you realize 
you’ve gained some strength and you‘re able to move 
about. (FGD: Pregnant woman)
Malaria health‑seeking behaviour: the role of ACT
Study participants do not adopt a single treatment-
seeking pattern for uncomplicated malaria. Some par-
ticipants visited health facilities immediately they felt 
unwell. Those diagnosed for malaria in the health facili-
ties were readily treated with an ACT as the only drug 
used for malaria treatment. Other community members 
visited drug stores to purchase any drug they deemed 
appropriate for the disease suspected or mentioned their 
health condition to the vendor who decides on which 
drug (among those listed in Table  3) is most appropri-
ate to be dispensed to cure the illness. Other community 
members initiated treatment with some left over drugs 
or start with some herbal preparations using herbs listed 
in Table 4. There were however, some respondents who 
used ACT alongside herbal preparations, whiles others 
used ACT for some days and switch over to any other 
drug or herbal preparation.
I agree with him. When you treat it traditionally 
and it still persists then opt for orthodox treatment 
in the health facility. (FGD, Man)
I think that even if the herbs will help, one has to go 
to the hospital first to get treatment, so that upon 
returning, the herbs can be used to supplement so 
that it will help. So the hospital is the best way to 
help ourselves in treating malaria (FGD, Woman)
we only pushed ground ginger into her anus but it 
didn’t work so I bought drugs at the drug shop. it did 
not work either so I took her to the hospital. (IDI, 
caretaker of a child less than five years)
You send the patient to hospital and after that you 
also cut some herbs like mango leaves, lemon and 
the “Timforgor” [the name of a herb] that she men-
tioned and the lemon leaves are mixed together 
(FGD, Woman)
Community members who used herbal preparations 
used parts of plants (roots, barks and stems and leaves) as 
itemized in Table 4.
Category of people who must not take ACT
The following categories of people were cited by a minor-
ity of community members as the group who could not 
take ACT: pregnant women, children less than 12 years 
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of age, diabetic patients, anemic persons and individu-
als with heart problems. Community members believed 
that ACT works on “blood” and therefore likely to affect 
foetus and children who are perceived to have very little 
blood. The following quotation show this position
Pregnant women should not take it because from 
what people say the drug is powerful and melts 
blood so I think it is not good for them. (FGD: Man)
I said an anaemic; because the drug is powerful and 
works with blood so such a person should not take 
the drug. (FGD: Man)
These perceptions were however held by the minority 
of discussants upon subsequent probing.
Reasons for self‑treatment, care‑seeking at health facilities 
and chemical shops for uncomplicated malaria in the 
communities
Generally, participants cited different reasons why they 
self-treat ailments such as malaria. Key among them were 
lack of money to either purchase medicines at the chemi-
cal shops or pay for cost at the health facilities, unavaila-
bility of means of transport in their communities to send 
them to a health facility and poor roads. Self-treatment 
was practiced to complement treatment that they receive 
at health facilities or when they perceive that treatment 
at the health facility failed. Another reason was patron-
izing the purchase of medicines of drug peddlers during 
their home visits to convince them of the potency of their 
medicines. Some quotes below illustrate some reasons 
cited for self- treatment:
If you realized you have malaria. We have transport 
problems to help us get to the health facility. You 
pluck some leaves, boil and take them (IDI, care-
taker of a child less than five years)
Supposing you get malaria and have to go to the hos-
pital, you’ll be required to pay; so if you don’t have 
money you give up and look for some herbs (FGD, 
Man)
My two year old child has been affected with 
malaria, and I’ve tried several times but did not 
work so I’m thinking of preparing herbs, as a support 
to see if that can work. So I believe that one can help 
(FGD caretaker of a child less than five years).
The following reasons were however cited for visiting 
health facilities: services rendered and the availability 
of laboratory services in the health facilities, the use of 
health insurance as a mode of financing services deliv-
ered at the health facilities, proximity to health facili-
ties and opportunity to visit and report the inability of 
a medicine provided at the facility to treat their disease 
condition, lack of knowledge of the cause of a disease 
condition they have been affected with as well as not 
getting cured after self-medication or seeking treatment 
at the drug store. They also cited the devastating effect 
of malaria and visits to health facilities is in response to 
calls to seek treatment at health facilities for all ailments, 
including malaria as some of the reasons. The quotes 
below illustrate some of the reasons cited for visiting 
health facilities:
Table 3 List of medicines sold to patients in the study area 
who present with fever/malaria at chemical stores: Decem-
ber 2009–October 2010
Type of anti‑malarial monotherapy Other medicines
Malafan (Sulfadoxine pyrimethamine) Paracetamol
Kinaquin 442 (Chloroquine) Oral Rehydration Salt
Chloroquine Glucose
Camoquine (Amodiaquine) Cafenol (Acetaminophen, Caf‑
feine)
Amodiaquine syrup Vitamin B complex
Amodiaquine suspension Quick Action (Caffein Ephedrine 
HCL, paracetamol)
Table 4 Table showing herbal plants used to  treat uncomplicated malaria in  the study area: December 2009–October 
2010
Local name of plant mentioned by respondents English name of plant Scientific name
“Duagyene‑wuraa” “Neam tree Leaves” Azadirachta indica
“Kashedua wuraa” “Acacia tree Leaves” Acacia glauca
“Acheamponwuraa” “Siam weed” Chromolaena odorata
“Amango‑wuraa” “Mango leaves” Magnifera indica
“Brofrewuraa‑a‑awo” “Dried pawpaw leaves” Carica papaya
“Teek‑wuraa” “Teak leaves” Tectona grandis
Ankaa‑twadee‑wuraa “Lime/Lemon leaves” Citrus vulgaris
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At the clinic, they have some machine. They will first 
take samples of your blood is to examine whether 
malaria parasites are in or not. So if it is found out 
that the parasites are in, you are given malaria 
treatment (FGD, man)
When the illness comes, I buy drugs but when it 
becomes very serious, I have to send the person to the 
health facility. (FGD, man)
The reasons cited for patronizing medicine in retail 
outlets (i.e. drug stores) included: distance to health 
facilities, if drugs given at the health facilities are per-
ceived not to be working well, as well as drug stores being 
immediate and accessible for solutions to health prob-
lems and medical advice
The health facility is very far from here as a result 
after the day’s work or when we wake up and feel 
body pains all over, we get some pain killer from the 
drug store before we look for other source of treat-
ment (FGD, Man)
If let us say I send the child to the clinic today being 
Friday, I’ll wait for a week to see if the child’s con-
dition does not improve, then I’ll buy drugs at the 
store. I will not send him/her to the clinic again 
(FGD, caretaker of a child less than five years)
Malaria diagnosis and treatment practices
Malaria diagnosis was based on clinical symptoms pre-
sented at health centres and drugs stores. The excerpts 
below support this finding.
…when you look at the person and the way he is 
standing, thus if the person says I am feeling cold, 
dizzy then you realized that it is fever (IDI, Drug 
store operator).
We don’t have a laboratory so we look at symptoms 
to prescribe but when we give them the treatment 
too they become alright (IDI, an in charge of Health 
Centre).
This notwithstanding health centre workers and drug 
store operators considerably adhere to the malaria treat-
ment guideline for children under 5  years of age and 
pregnant women as revealed in the responses below.
For the under-fives, if we check and he is below the 
age that he cannot take the Amodiaquine and he is 
feverish we give para [paracetamol] and advice that 
they are taken to the hospital (IDI, a drug shop oper-
ator).
We do not give any pregnant woman drugs over here. 
At our workshops we are thought that when someone 
is pregnant it is only the doctor who can prescribe 
medicine for her so we do not sell malaria and other 
drugs to pregnant women (IDI, a drug shop operator).
Category of staff, hours of operation and type of services 
provided in health centres and chemical stores
The categories of staff at Health Centers are mainly 
enrolled nurses and Physician Assistants who are in-
charge of consultation and health service delivery. They 
are supported by Community Health Officers who are in 
charge of history taking and medicine dispensary. Chem-
ical stores are operated by chemical sellers who have 
received some basic form of training in medicine dispen-
sary from the pharmacy council of Ghana. This is what 
a respondent had to say about the category of staff who 
work at the health center.
I am a physician assistant but you know we have 
community health officers over there (she points to a 
section of the health facility). If any FP [Family plan-
ning] patient comes, they go to their [community 
health officer] office and I will be working at the con-
sulting room (IDI, In-Charge, Health Center).
With regards to the hours of operation, whilst health 
centers operate from 8 a.m. to 5 p.m. on working days, 
drug shop operators work from 6 a.m. to 8 p.m. a daily on 
both week days and weekends. However, it is interesting 
to note that both health centers and drug shops operate 
as and when they are called upon to attend to patients/
clients as illustrated in the quote below.
I work from 8 am to 5 pm on week days; after that 
when any case comes they come and call me some-
times on weekends. So I’ll work for 24  h (IDI, In-
Charge, Health Center).
Health services provided by health centers are mainly 
diagnosis and treatment of uncomplicated malaria. Other 
services include the provision of reproductive and child 
health care such as family planning services, antena-
tal and post-natal care. Like the health centers, chemi-
cal sellers provide treatment for basic ailments based on 
clinical symptoms but refer children and other clients 
whose condition they perceive as “higher than” them to 
the health centers.
For the under-fives if we check and he is below the 
age that he cannot take the Amodiaquine and he is 
still feverish we give paracetamol and advice that 
they are taken to the hospital (IDI, drug shop opera-
tor).
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Table 5 gives a summary of category of staff, hours of 
operation and the type of services provided in health 
centers and chemical stores.
Discussion
There have been several studies on the knowledge of 
ACT among communities and health workers in sub-
Saharan Africa [12–16] and their use can be successfully 
integrated into the malaria home management pro-
gramme [13]. However a study in Nigeria [14] revealed 
that a significant number of community members have 
no knowledge of ACT, though they could have been 
treated with ACT. This study adequately demonstrates 
some level of knowledge of ACT among community 
members that were involved in this study. The challenge 
about knowledge is the ability of discussants/respondents 
to mention the name of the actual ACT that they mean. 
This call for the need for national malaria programme 
managers to come out with short names or abbreviated 
versions of names of ACT. Community members should 
be adequately educated on this abbreviated versions or 
short names to enhance its usage. Disposition related to 
medicine use vary among communities. They are either 
negative or positive. Whilst a study in Malawi recorded 
positive disposition about use of artemether–lumefan-
trine [15], this study recorded some negative experiences 
by community members who used Ghana’s first-line 
malaria treatment, artesunate–amodiaquine. Some of the 
negative experiences were dizziness, drowsiness, “body 
weakness”. These experiences could create perceptions 
that may have negative consequence for the successful 
implementation of health programmes, as happened in 
Nigeria during a polio immunization campaign [16], if 
not properly managed.
Experiences of patients and community level interpre-
tation of the use of medication has the tendency to fos-
ter continuous use of such medicines or rejection. In a 
study to assess the barriers to malaria mass drug admin-
istration [17], it was revealed that fears of perceived side 
effects such as dizziness, stomach ache and the quantity 
of medicines that needed to be taken contributed to poor 
adherence. Women who intended to get pregnant refused 
and the state of their pregnancy also contributed to the 
refusals. This study recorded similar findings. Respond-
ents indicated that they feel dizzy when they take ACT. 
A minority group of respondents cited specific group of 
people such as pregnant women children and diabetics as 
people who should not take ACT. This position was not 
corroborated by Dial et  al. [17]. Though this perception 
was held by a minority group, it is likely that women and 
children who are at risk may be discouraged from tak-
ing ACT. This could lead to poor treatment outcomes. 
National malaria control programme managers should 
strengthen education on adherence to curtail this mis-
conception. Another study [18] on adherence and uptake 
of ACTS in northern Ghana also did not indicate the 
caliber of people that must not take ACTs. In light of the 
effects these may have on compliance, experiences in the 
malaria control efforts studies have come up with some 
suggestions. A study in Tanzania [19] suggested incor-
porating local beliefs and practices surrounding use of 
anti-malarials into programmatic goals to significantly 
improve uptake malaria control interventions. In Malawi 
[15], caregivers deliberately altered dosing regimens of 
artemether–lumefantrine and dihydoartemisinin–pipe-
raquine depending on whether they perceived the medi-
cation to be strong or weak. The study by Eving et al. [15] 
suggested further optimization of anti-malarial adher-
ence among children, with the development of anti-
malarials with pharmacological properties that allow 
user-friendly administration with easy and simplified 
dosing schedules.
The use of herbal preparations in treatment of dis-
eases is a well-documented phenomenon in many parts 
of Africa [20–24]. Ethno pharmacological studies on the 
use of herbal remedies for malaria in Ghana [25] con-
cluded that the use of herbal remedies to treat malaria 
was a common practice. This study also documents the 
continual use of herbal preparations in treating malaria. 
Many unexpected health problems could arise if this not 
checked and properly managed. Sometimes, doses are 
not too clear to the end user, chemical composition and 
toxicity effects are also not clearly documented. These 
and other contributory factors could make end users vul-
nerable to other health problems that may lead to fatali-
ties including deaths.
Treatment practices including self-medication with 
anti-malarials has been widely reported in many parts of 
Africa [26–31], reasons cited were health facilities chal-
lenges such as shortages of medicines, long waiting time, 
perceived quality of services, location of facilities and dis-
tance from homes, inability to pay for health care costs, 
and lack of freedom to choose medicines of their choice 
[27, 32]. Drug shops still remain one of the significant 
sources of anti-malarials distributed to communities [26]; 
though the main source of anti-malarials, the knowledge 
of those in-charge of the drug shops was not satisfactory 
when it comes to malaria case management and other 
diseases as previously documented [26]
Also, the findings on malaria diagnosis and treatment 
practices corroborates the fact that, the lack of laborato-
ries and malaria test kits in lower health facilities are the 
major setback in the diagnosis and treatment of malaria 
in Ghana. As regards the WHO malaria treatment guide-
lines [33] adopted by Ghana suspected malaria cases 
are to be tested and confirmed before malaria drugs are 
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prescribed. There are efforts by the Ghana Health Ser-
vices to supply malaria test kits to health centres but the 
supply has been erratic
The categories of health staff in rural health facili-
ties play a major role in the health delivery process. 
The absence of qualified staff serves as a big disincen-
tive to rural and deprived communities. Their continu-
ous presence in the health facilities and how easily they 
are accessible contributes immensely to the timely pro-
vision of cure for ailments including uncomplicated 
malaria. The finding on the category of staff in health 
facilities in this study is in agreement with findings 
from a systematic review on motivation and retention 
of health staff in rural communities in developing coun-
tries [34]. The review emphasized that, health worker 
retention is therefore critical for health system perfor-
mance and efforts must be put in place to ensure their 
motivation [34].
Conclusion
There is no clear-cut trajectory for management of 
uncomplicated malaria in the study area. Different 
approaches are adopted when treating malaria. Many 
factors determine how community members seek health 
when they are unwell. These include drug availability, 
sociocultural behaviour and cost. The use of herbal prep-
arations to treat many ailments including uncomplicated 
malaria is very common. There is need for community 
education to influence behaviour on the management of 
malaria to achieve real gains from ACT use.
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